Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  AUSTRALIAN SECURITIES EXCHANGE LIMITED  >  CSL Limited    CSL   AU000000CSL8

CSL LIMITED

(CSL)
  Report  
End-of-day quote. End-of-day quote AUSTRALIAN SECURITIES EXCHANGE LIMITED - 09/20
234.5 AUD   -0.22%
09/12CSL : Update - Dividend/Distribution - CSL
PU
09/10CSL LIMITED : Ex-dividend day for final dividend
FA
08/30CSL : Change of Director's Interest Notice
PU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Securities Exc…
09/16/2019 09/17/2019 09/18/2019 09/19/2019 09/20/2019 Date
230.38(c) 234.82(c) 234.77(c) 235.02(c) 234.5 Last
970 768 844 844 799 249 1 667 138 1 009 740 Volume
-0.13% +1.93% -0.02% +0.11% -0.22% Change
More quotes
Financials (AUD)
Sales 2020 13 257 M
EBIT 2020 4 023 M
Net income 2020 3 039 M
Debt 2020 5 736 M
Yield 2020 1,23%
Sales 2021 14 858 M
EBIT 2021 4 595 M
Net income 2021 3 548 M
Debt 2021 5 551 M
Yield 2021 1,42%
P/E ratio 2020 35,0x
P/E ratio 2021 30,0x
EV / Sales2020 8,46x
EV / Sales2021 7,54x
Capitalization 106 B
More Financials
Company
CSL Limited is a biotherapeutics company that develops and delivers biotherapies. The Company's principal activities are research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. Its segments include CSL Behring, Seqirus and CSL Intellectual Property.... 
Sector
Pharmaceuticals
Calendar
10/15 | 10:00pmShareholder meeting
More about the company
Surperformance© ratings of CSL Limited
Trading Rating : Investor Rating :
More Ratings
Latest news on CSL LIMITED
09/12CSL : Update - Dividend/Distribution - CSL
PU
09/10CSL LIMITED : Ex-dividend day for final dividend
FA
08/30CSL : Change of Director's Interest Notice
PU
08/23CSL : Seqirus to Present Data on Pandemic and Seasonal Influenza Vaccines at OPT..
AQ
08/23CSL : Change of Director's Interest Notice
PU
08/14CSL : Update - Dividend/Distribution - CSL
PU
08/13CSL : Annual Profit Rises On Immunoglobulin, Flu-Vaccine Sales
DJ
07/18CSL LIMITED : - Anjana Narain to Lead Seqirus Influenza Vaccines Business
AQ
07/16CSL : Seqirus is First-to-Market with U.S. 2019/20 Influenza Vaccines
AQ
06/21CSL : Behring to showcase clinical advances and insights in Chronic Inflammatory..
AQ
More news
Analyst Recommendations on CSL LIMITED
More recommendations
Sector news : Biopharmaceuticals
09/20DR REDDY LABORATORIES : . Reddy's Suspends Shipments of Ranitidine
DJ
09/20ALLERGAN : Form 8.3 -
DJ
09/20NOVO NORDISK : FDA Approves Novo Nordisk's Rybelsus Diabetes Tablets
DJ
09/20ZOETIS : Says EC Grants Marketing Authorization for Antiparasitic Medication for..
DJ
09/20MERCK : Pfizer Get CHMP Positive Opinion for Bavencio
DJ
More sector news : Biopharmaceuticals
Chart CSL LIMITED
Duration : Period :
CSL Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CSL LIMITED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 239,02  AUD
Last Close Price 234,50  AUD
Spread / Highest target 11,3%
Spread / Average Target 1,93%
Spread / Lowest Target -10,4%
EPS Revisions
Managers
NameTitle
Paul Roger Perreault Chief Executive Officer, Executive Director & MD
Brian Anthony McNamee Chairman
David Mark Lamont Chief Financial Officer
Andrew Cuthbertson Chief Scientific Officer
Charmaine Gittleson Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
CSL LIMITED26.65%72 057
BIOGEN INC.-20.65%43 459
ALEXION PHARMACEUTICALS8.54%23 694
SAMSUNG BIOLOGICS CO LTD--.--%18 246
GRIFOLS15.63%18 022
BIOMARIN PHARMACEUTICAL INC.-11.98%13 639